{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:39:45Z","timestamp":1792067985776,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12HS026383"],"award-info":[{"award-number":["K12HS026383"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["2K24DA042720"],"award-info":[{"award-number":["2K24DA042720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA060329"],"award-info":[{"award-number":["K23DA060329"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA057672"],"award-info":[{"award-number":["R01DA057672"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.josat.2026.209893","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:58:27Z","timestamp":1769500707000},"page":"209893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["\u201cIt's like scratching at the door\u201d: Experiences of outpatient buprenorphine low dose initiation among people using fentanyl"],"prefix":"10.1016","volume":"184","author":[{"given":"Leslie W.","family":"Suen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyssa","family":"Samayoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Scarpetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip O.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2026.209893_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13722-021-00244-8","article-title":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: A systematic review","volume":"16","author":"Adams","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.209893_bb0010","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2023"},{"issue":"2","key":"10.1016\/j.josat.2026.209893_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sapharm.2018.04.001","article-title":"Using the Behaviour Change Wheel to explore potential strategies for minimising harms from non-recreational prescription medicine sharing","volume":"15","author":"Beyene","year":"2019","journal-title":"Research in Social & Administrative Pharmacy: RSAP"},{"key":"10.1016\/j.josat.2026.209893_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: Narrative review and clinical significance related to illicitly manufactured fentanyl","author":"Bird","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.josat.2026.209893_bb0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jamapsychiatry.2013.4546","article-title":"Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial","volume":"71","author":"Bowen","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2026.209893_bb0030","article-title":"Low-dose buprenorphine initiation in hospitalized adults with opioid use disorder: A retrospective cohort analysis","author":"Button","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2026.209893_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ADM.0000000000000945","article-title":"Low dose initiation of buprenorphine: A narrative review and practical approach","volume":"16","author":"Cohen","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.209893_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.josat.2026.209893_bb0045","series-title":"SF to expand combination shelter-opioid treatment program for homeless residents","author":"Cooke","year":"2025"},{"issue":"5","key":"10.1016\/j.josat.2026.209893_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40261-021-01032-7","article-title":"The pharmacology of buprenorphine microinduction for opioid use disorder","volume":"41","author":"De Aquino","year":"2021","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.josat.2026.209893_bb0055","article-title":"Prescribing buprenorphine by telehealth: Lessons from San Francisco amidst a changing regulatory landscape","author":"Hom","year":"2025","journal-title":"Health Affairs Forefront"},{"issue":"1","key":"10.1016\/j.josat.2026.209893_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12954-024-00998-9","article-title":"Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: A retrospective cohort study","volume":"21","author":"Jones","year":"2024","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.209893_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2026.209893_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implementation Science: IS"},{"key":"10.1016\/j.josat.2026.209893_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001154","article-title":"The Howard Street method: A community pharmacy-led low dose overlap buprenorphine initiation protocol for individuals using fentanyl","author":"Noel","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"15","key":"10.1016\/j.josat.2026.209893_bb0080","doi-asserted-by":"crossref","first-page":"eabf0364","DOI":"10.1126\/sciadv.abf0364","article-title":"Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction","volume":"7","author":"Pantazis","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/j.josat.2026.209893_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmmh.2022.100151","article-title":"Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study","volume":"2","author":"Poulsen","year":"2022","journal-title":"SSM. Mental Health"},{"key":"10.1016\/j.josat.2026.209893_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.209893_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54950","article-title":"Mindfulness training vs recovery support for opioid use, craving, and anxiety during buprenorphine treatment: A randomized clinical trial","volume":"8","author":"Schuman-Olivier","year":"2025","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2026.209893_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ntr\/ntac242","article-title":"Promoting and maintaining changes in smoking behavior for patients following discharge from a smoke-free mental health inpatient stay: Development of a complex intervention using the behavior change wheel","volume":"25","author":"Shoesmith","year":"2023","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.josat.2026.209893_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","author":"Sordo","year":"2017","journal-title":"BMJ (Clinical Research Edition)"},{"issue":"4","key":"10.1016\/j.josat.2026.209893_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ADM.0000000000000952","article-title":"A plea from people who use drugs to clinicians: New ways to initiate buprenorphine are urgently needed in the fentanyl era","volume":"16","author":"Sue","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.209893_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.56253","article-title":"Outpatient low-dose initiation of buprenorphine for people using fentanyl","volume":"8","author":"Suen","year":"2025","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.209893_bb0120","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000961","article-title":"Rapid overlap initiation protocol using low dose buprenorphine for opioid use disorder treatment in an outpatient setting: A case series","author":"Suen","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.209893_bb0130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MJT.0000000000001573","article-title":"Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study","volume":"30","author":"Sulakvelidze","year":"2023","journal-title":"American Journal of Therapeutics"},{"issue":"6","key":"10.1016\/j.josat.2026.209893_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"key":"10.1016\/j.josat.2026.209893_bb0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.161.5.654","article-title":"Factors associated with relapse among opiate addicts in an out-patient detoxification programme","volume":"161","author":"Unnithan","year":"1992","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:28:41Z","timestamp":1782188921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S2949875926000135"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209893","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cIt's like scratching at the door\u201d: Experiences of outpatient buprenorphine low dose initiation among people using fentanyl","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209893"}}